Global Immune Globulin Subcutaneous Market Research Report 2020
Table of Contents1 Immune Globulin Subcutaneous Market Overview
1.1 Product Overview and Scope of Immune Globulin Subcutaneous
1.2 Immune Globulin Subcutaneous Segment by Type
1.2.1 Global Immune Globulin Subcutaneous Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Immune Globulin Subcutaneous Segment by Application
1.3.1 Immune Globulin Subcutaneous Sales Comparison by Application: 2020 VS 2026
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Immune Globulin Subcutaneous Market Size Estimates and Forecasts
1.4.1 Global Immune Globulin Subcutaneous Revenue 2015-2026
1.4.2 Global Immune Globulin Subcutaneous Sales 2015-2026
1.4.3 Immune Globulin Subcutaneous Market Size by Region: 2020 Versus 2026
2 Global Immune Globulin Subcutaneous Market Competition by Manufacturers
2.1 Global Immune Globulin Subcutaneous Sales Market Share by Manufacturers (2015-2020)
2.2 Global Immune Globulin Subcutaneous Revenue Share by Manufacturers (2015-2020)
2.3 Global Immune Globulin Subcutaneous Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Immune Globulin Subcutaneous Manufacturing Sites, Area Served, Product Type
2.5 Immune Globulin Subcutaneous Market Competitive Situation and Trends
2.5.1 Immune Globulin Subcutaneous Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Immune Globulin Subcutaneous Players (Opinion Leaders)
3 Immune Globulin Subcutaneous Retrospective Market Scenario by Region
3.1 Global Immune Globulin Subcutaneous Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Immune Globulin Subcutaneous Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Immune Globulin Subcutaneous Market Facts & Figures by Country
3.3.1 North America Immune Globulin Subcutaneous Sales by Country
3.3.2 North America Immune Globulin Subcutaneous Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Immune Globulin Subcutaneous Market Facts & Figures by Country
3.4.1 Europe Immune Globulin Subcutaneous Sales by Country
3.4.2 Europe Immune Globulin Subcutaneous Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Immune Globulin Subcutaneous Market Facts & Figures by Region
3.5.1 Asia Pacific Immune Globulin Subcutaneous Sales by Region
3.5.2 Asia Pacific Immune Globulin Subcutaneous Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Immune Globulin Subcutaneous Market Facts & Figures by Country
3.6.1 Latin America Immune Globulin Subcutaneous Sales by Country
3.6.2 Latin America Immune Globulin Subcutaneous Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Immune Globulin Subcutaneous Market Facts & Figures by Country
3.7.1 Middle East and Africa Immune Globulin Subcutaneous Sales by Country
3.7.2 Middle East and Africa Immune Globulin Subcutaneous Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Immune Globulin Subcutaneous Historic Market Analysis by Type
4.1 Global Immune Globulin Subcutaneous Sales Market Share by Type (2015-2020)
4.2 Global Immune Globulin Subcutaneous Revenue Market Share by Type (2015-2020)
4.3 Global Immune Globulin Subcutaneous Price Market Share by Type (2015-2020)
4.4 Global Immune Globulin Subcutaneous Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Immune Globulin Subcutaneous Historic Market Analysis by Application
5.1 Global Immune Globulin Subcutaneous Sales Market Share by Application (2015-2020)
5.2 Global Immune Globulin Subcutaneous Revenue Market Share by Application (2015-2020)
5.3 Global Immune Globulin Subcutaneous Price by Application (2015-2020)
6 Company Profiles and Key Figures in Immune Globulin Subcutaneous Business
6.1 Baxter
6.1.1 Corporation Information
6.1.2 Baxter Description, Business Overview and Total Revenue
6.1.3 Baxter Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Baxter Products Offered
6.1.5 Baxter Recent Development
6.2 CSL
6.2.1 CSL Immune Globulin Subcutaneous Production Sites and Area Served
6.2.2 CSL Description, Business Overview and Total Revenue
6.2.3 CSL Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2015-2020)
6.2.4 CSL Products Offered
6.2.5 CSL Recent Development
7 Immune Globulin Subcutaneous Manufacturing Cost Analysis
7.1 Immune Globulin Subcutaneous Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Immune Globulin Subcutaneous
7.4 Immune Globulin Subcutaneous Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Immune Globulin Subcutaneous Distributors List
8.3 Immune Globulin Subcutaneous Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Immune Globulin Subcutaneous Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Immune Globulin Subcutaneous by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Immune Globulin Subcutaneous by Type (2021-2026)
10.2 Immune Globulin Subcutaneous Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Immune Globulin Subcutaneous by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Immune Globulin Subcutaneous by Application (2021-2026)
10.3 Immune Globulin Subcutaneous Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Immune Globulin Subcutaneous by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Immune Globulin Subcutaneous by Region (2021-2026)
10.4 North America Immune Globulin Subcutaneous Estimates and Projections (2021-2026)
10.5 Europe Immune Globulin Subcutaneous Estimates and Projections (2021-2026)
10.6 Asia Pacific Immune Globulin Subcutaneous Estimates and Projections (2021-2026)
10.7 Latin America Immune Globulin Subcutaneous Estimates and Projections (2021-2026)
10.8 Middle East and Africa Immune Globulin Subcutaneous Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Immune Globulin Subcutaneous Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Immune Globulin Subcutaneous Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Immune Globulin Subcutaneous Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Immune Globulin Subcutaneous Manufacturers Covered in This Study
Table 5. Global Immune Globulin Subcutaneous Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Immune Globulin Subcutaneous Sales Share by Manufacturers (2015-2020)
Table 7. Global Immune Globulin Subcutaneous Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Immune Globulin Subcutaneous Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Immune Globulin Subcutaneous Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Immune Globulin Subcutaneous Sales Sites and Area Served
Table 11. Manufacturers Immune Globulin Subcutaneous Product Types
Table 12. Global Immune Globulin Subcutaneous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Immune Globulin Subcutaneous by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Globulin Subcutaneous as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Immune Globulin Subcutaneous Players
Table 16. Global Immune Globulin Subcutaneous Sales (MT) by Region (2015-2020)
Table 17. Global Immune Globulin Subcutaneous Sales Market Share by Region (2015-2020)
Table 18. Global Immune Globulin Subcutaneous Revenue (Million US$) by Region (2015-2020)
Table 19. Global Immune Globulin Subcutaneous Revenue Market Share by Region (2015-2020)
Table 20. North America Immune Globulin Subcutaneous Sales by Country (2015-2020) (MT)
Table 21. North America Immune Globulin Subcutaneous Sales Market Share by Country (2015-2020)
Table 22. North America Immune Globulin Subcutaneous Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Immune Globulin Subcutaneous Revenue Market Share by Country (2015-2020)
Table 24. Europe Immune Globulin Subcutaneous Sales by Country (2015-2020) (MT)
Table 25. Europe Immune Globulin Subcutaneous Sales Market Share by Country (2015-2020)
Table 26. Europe Immune Globulin Subcutaneous Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Immune Globulin Subcutaneous Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Immune Globulin Subcutaneous Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Immune Globulin Subcutaneous Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Immune Globulin Subcutaneous Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Immune Globulin Subcutaneous Revenue Market Share by Region (2015-2020)
Table 32. Latin America Immune Globulin Subcutaneous Sales by Country (2015-2020) (MT)
Table 33. Latin America Immune Globulin Subcutaneous Sales Market Share by Country (2015-2020)
Table 34. Latin America Immune Globulin Subcutaneous Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Immune Globulin Subcutaneous Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Immune Globulin Subcutaneous Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Immune Globulin Subcutaneous Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Immune Globulin Subcutaneous Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Immune Globulin Subcutaneous Revenue Market Share by Country (2015-2020)
Table 40. Global Immune Globulin Subcutaneous Sales (MT) by Type (2015-2020)
Table 41. Global Immune Globulin Subcutaneous Sales Share by Type (2015-2020)
Table 42. Global Immune Globulin Subcutaneous Revenue (Million US$) by Type (2015-2020)
Table 43. Global Immune Globulin Subcutaneous Revenue Share by Type (2015-2020)
Table 44. Global Immune Globulin Subcutaneous Price (USD/Kg) by Type (2015-2020)
Table 45. Global Immune Globulin Subcutaneous Sales (MT) by Application (2015-2020)
Table 46. Global Immune Globulin Subcutaneous Sales Market Share by Application (2015-2020)
Table 47. Global Immune Globulin Subcutaneous Sales Growth Rate by Application (2015-2020)
Table 48. Baxter Immune Globulin Subcutaneous Corporation Information
Table 49. Baxter Description and Business Overview
Table 50. Baxter Immune Globulin Subcutaneous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. Baxter Main Product
Table 52. Baxter Recent Development
Table 53. CSL Immune Globulin Subcutaneous Corporation Information
Table 54. CSL Corporation Information
Table 55. CSL Immune Globulin Subcutaneous Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. CSL Main Product
Table 57. CSL Recent Development
Table 58. Sales Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Immune Globulin Subcutaneous Distributors List
Table 61. Immune Globulin Subcutaneous Customers List
Table 62. Market Key Trends
Table 63. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 64. Key Challenges
Table 65. Global Immune Globulin Subcutaneous Sales (MT) Forecast by Type (2021-2026)
Table 66. Global Immune Globulin Subcutaneous Sales Market Share Forecast by Type (2021-2026)
Table 67. Global Immune Globulin Subcutaneous Revenue (Million US$) Forecast by Type (2021-2026)
Table 68. Global Immune Globulin Subcutaneous Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 69. Global Immune Globulin Subcutaneous Sales (MT) Forecast by Application (2021-2026)
Table 70. Global Immune Globulin Subcutaneous Revenue (Million US$) Forecast by Application (2021-2026)
Table 71. Global Immune Globulin Subcutaneous Sales (MT) Forecast by Region (2021-2026)
Table 72. Global Immune Globulin Subcutaneous Sales Market Share Forecast by Region (2021-2026)
Table 73. Global Immune Globulin Subcutaneous Revenue Forecast by Region (2021-2026) (US$ Million)
Table 74. Global Immune Globulin Subcutaneous Revenue Market Share Forecast by Region (2021-2026)
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of FiguresFigure 1. Picture of Immune Globulin Subcutaneous
Figure 2. Global Immune Globulin Subcutaneous Sales Market Share by Type: 2020 VS 2026
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Immune Globulin Subcutaneous Consumption Market Share by Application: 2020 VS 2026
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Global Immune Globulin Subcutaneous Market Size 2015-2026 (US$ Million)
Figure 10. Global Immune Globulin Subcutaneous Sales Capacity (MT) (2015-2026)
Figure 11. Global Immune Globulin Subcutaneous Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Immune Globulin Subcutaneous Sales Share by Manufacturers in 2020
Figure 13. Global Immune Globulin Subcutaneous Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Immune Globulin Subcutaneous Revenue in 2019
Figure 15. Immune Globulin Subcutaneous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Immune Globulin Subcutaneous Sales Market Share by Region (2015-2020)
Figure 17. Global Immune Globulin Subcutaneous Sales Market Share by Region in 2019
Figure 18. Global Immune Globulin Subcutaneous Revenue Market Share by Region (2015-2020)
Figure 19. Global Immune Globulin Subcutaneous Revenue Market Share by Region in 2019
Figure 20. North America Immune Globulin Subcutaneous Sales Market Share by Country in 2019
Figure 21. North America Immune Globulin Subcutaneous Revenue Market Share by Country in 2019
Figure 22. U.S. Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 23. U.S. Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 25. Canada Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Immune Globulin Subcutaneous Sales Market Share by Country in 2019
Figure 27. Europe Immune Globulin Subcutaneous Revenue Market Share by Country in 2019
Figure 28. Germany Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 29. Germany Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 31. France Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 33. U.K. Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 35. Italy Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 37. Russia Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Immune Globulin Subcutaneous Sales Market Share by Region in 2019
Figure 39. Asia Pacific Immune Globulin Subcutaneous Revenue Market Share by Region in 2019
Figure 40. China Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 41. China Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 43. Japan Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 45. South Korea Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 47. India Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 49. Australia Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 51. Taiwan Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 53. Indonesia Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 55. Thailand Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 57. Malaysia Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 59. Philippines Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 61. Vietnam Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Immune Globulin Subcutaneous Sales Market Share by Country in 2019
Figure 63. Latin America Immune Globulin Subcutaneous Revenue Market Share by Country in 2019
Figure 64. Mexico Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 65. Mexico Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 67. Brazil Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 69. Argentina Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Immune Globulin Subcutaneous Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Immune Globulin Subcutaneous Revenue Market Share by Country in 2019
Figure 72. Turkey Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 73. Turkey Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 75. Saudi Arabia Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Immune Globulin Subcutaneous Sales Growth Rate (2015-2020) (MT)
Figure 77. U.A.E Immune Globulin Subcutaneous Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Immune Globulin Subcutaneous by Type (2015-2020)
Figure 79. Sales Market Share of Immune Globulin Subcutaneous by Type in 2019
Figure 80. Revenue Share of Immune Globulin Subcutaneous by Type (2015-2020)
Figure 81. Revenue Market Share of Immune Globulin Subcutaneous by Type in 2019
Figure 82. Global Immune Globulin Subcutaneous Sales Growth by Type (2015-2020) (MT)
Figure 83. Global Immune Globulin Subcutaneous Sales Market Share by Application (2015-2020)
Figure 84. Global Immune Globulin Subcutaneous Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Immune Globulin Subcutaneous by Application (2015-2020)
Figure 86. Global Revenue Share of Immune Globulin Subcutaneous by Application in 2020
Figure 87. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Price Trend of Key Raw Materials
Figure 90. Manufacturing Cost Structure of Immune Globulin Subcutaneous
Figure 91. Manufacturing Process Analysis of Immune Globulin Subcutaneous
Figure 92. Immune Globulin Subcutaneous Industrial Chain Analysis
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Porter's Five Forces Analysis
Figure 96. North America Immune Globulin Subcutaneous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 97. North America Immune Globulin Subcutaneous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 98. Europe Immune Globulin Subcutaneous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 99. Europe Immune Globulin Subcutaneous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 100. Latin America Immune Globulin Subcutaneous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 101. Latin America Immune Globulin Subcutaneous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 102. Middle East and Africa Immune Globulin Subcutaneous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 103. Middle East and Africa Immune Globulin Subcutaneous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Asia Pacific Immune Globulin Subcutaneous Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 105. Asia Pacific Immune Globulin Subcutaneous Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed